These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32542436)

  • 1. [Molecular therapies in childhood neuromuscular disorders-definite hope versus unknown pitfalls].
    Blaschek A; Vill K; Müller-Felber W; Schara U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jul; 63(7):891-897. PubMed ID: 32542436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic therapies for inherited neuromuscular disorders.
    Scoto M; Finkel R; Mercuri E; Muntoni F
    Lancet Child Adolesc Health; 2018 Aug; 2(8):600-609. PubMed ID: 30119719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Innovative therapeutic approaches for hereditary neuromuscular diseases].
    Kirschner J; Schoser B
    Nervenarzt; 2018 Oct; 89(10):1115-1122. PubMed ID: 30171303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapeutic strategies and relevant clinical trials in neuromuscular disorder in China.
    Hu C; Li X
    Gene Ther; 2020 Aug; 27(7-8):321-328. PubMed ID: 32591735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene therapies for neuromuscular diseases].
    Saffari A; Weiler M; Hoffmann GF; Ziegler A
    Nervenarzt; 2019 Aug; 90(8):809-816. PubMed ID: 31286145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the path to evidence-based therapy in neuromuscular disorders.
    Younger DS
    Handb Clin Neurol; 2023; 195():315-358. PubMed ID: 37562877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening of neuromuscular diseases.
    Dangouloff T; Boemer F; Servais L
    Neuromuscul Disord; 2021 Oct; 31(10):1070-1080. PubMed ID: 34620514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of dystrophinopathy by skin biopsy.
    Niiyama T; Higuchi I; Sakoda S; Matsumura T; Fukunaga H; Osame M
    Muscle Nerve; 2002 Mar; 25(3):398-401. PubMed ID: 11870717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic therapies and respiratory outcomes in patients with neuromuscular disease.
    Chen D; Ni J; Buu M
    Curr Opin Pediatr; 2024 Jun; 36(3):296-303. PubMed ID: 38655811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pharmacotherapies for genetic neuromuscular disorders: opportunities and challenges.
    Ricci F; Vacchetti M; Brusa C; Vercelli L; Davico C; Vitiello B; Mongini T
    Expert Rev Clin Pharmacol; 2019 Aug; 12(8):757-770. PubMed ID: 31220956
    [No Abstract]   [Full Text] [Related]  

  • 11. Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.
    Sardone V; Zhou H; Muntoni F; Ferlini A; Falzarano MS
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28379182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal molecular diagnosis of inherited neuromuscular diseases: Duchenne/Becker muscular dystrophy, myotonic dystrophy type 1 and spinal muscular atrophy.
    Esposito G; Ruggiero R; Savarese M; Savarese G; Tremolaterra MR; Salvatore F; Carsana A
    Clin Chem Lab Med; 2013 Dec; 51(12):2239-45. PubMed ID: 23729582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progress of AAV-mediated gene therapy in neuromuscular disorders.
    Aguti S; Malerba A; Zhou H
    Expert Opin Biol Ther; 2018 Jun; 18(6):681-693. PubMed ID: 29781327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seeking a better landscape for therapy development in neuromuscular disorders.
    Larkindale J; Porter JD
    Muscle Nerve; 2018 Jan; 57(1):16-19. PubMed ID: 28881009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome engineering: a new approach to gene therapy for neuromuscular disorders.
    Nelson CE; Robinson-Hamm JN; Gersbach CA
    Nat Rev Neurol; 2017 Nov; 13(11):647-661. PubMed ID: 28960187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How is Physical Activity Measured in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy?
    Uher D; Yoon L; Garber CE; Montes J
    J Neuromuscul Dis; 2023; 10(5):897-914. PubMed ID: 37424475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for neuromuscular disorders: prospects and ethics.
    Ryan MM
    Arch Dis Child; 2022 May; 107(5):421-426. PubMed ID: 34462265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep disordered breathing: Assessment and therapy in the age of emerging neuromuscular therapies.
    Gurbani N; Pascoe JE; Katz S; Sawnani H
    Pediatr Pulmonol; 2021 Apr; 56(4):700-709. PubMed ID: 32720756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromuscular disorders in the omics era.
    Dabaj I; Ducatez F; Marret S; Bekri S; Tebani A
    Clin Chim Acta; 2024 Jan; 553():117691. PubMed ID: 38081447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal gene therapy for neuromuscular diseases - opportunities and limitations.
    Kirschner J
    J Perinat Med; 2021 Oct; 49(8):1011-1015. PubMed ID: 34499826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.